I just finished listening to the webinar. As a shareholder, it was worth the time. Alfie ran through the presentation, but added a little bit of nuance and extra detail in places.
The key (little) things I took notice of were:
- Traceability is high with our product. Companies want to be confident they know where they are sourcing things form and this is a bonus for our product.
- The "Fibre First" policy includes the production of Nufolium
- The Grasim collaboration agreement allows the parties to work with third parties. SO the lockdown is not as devastating as it could be. They have had initial discussions around this.
- It appears that the processing of raw materials into MC is being done in Australia (I'm not sure if I interpreted that correctly)
- Trademarks or royalties are likely to be the first streams of revnue
- Still expecting trials with companies to commence within the next 6 months
- Not going to spend out money on New Forrest (so I assume a lot of dilution)
- No plans to provide sizeable free samples to companies anymore
- Codi testing can't be completed until we have provided them fibre to test, which hasn't occured yet
- The cost of our fibre is likely to be about the same as rayon, although even if it is more expensive, there should be plenty of demand
- We probably won't be able to supply the really big labels until we are producing very large quantities that meet each individual company's specifications
- Have halved cash burn recently, burning about $50k per month
They answered three of the four questions I proposed. I'm not sure if they didn't ask my fourth question because I asked too many questions and they wanted to get to others or because I asked about how much dilution we could expect in the future to produce New Forrest.
The webinar was recorded, so I suspect it will be made available on the Nanollose website sometime soon.
Add to My Watchlist
What is My Watchlist?
